COLLABORATION AGREEMENTCollaboration Agreement • November 9th, 2020 • NantKwest, Inc. • Biological products, (no disgnostic substances) • California
This COLLABORATION AGREEMENT (this “Agreement”) is entered into as of August 21, 2020 (“Effective Date”) by and between ImmunityBio, Inc., a Delaware corporation, having a principal place of business at 9920 Jefferson Blvd., Culver City, California 90232 (“ImmunityBio”) and NantKwest, Inc., a Delaware corporation, having a principal place of business at 2040 E. Mariposa Ave. El Segundo, CA 90245 (“NantKwest”). ImmunityBio and NantKwest are each referred to herein by name or, individually, as a “Party” or, collectively, as “Parties.”
SUBLEASE AGREEMENTSublease Agreement • November 9th, 2020 • NantKwest, Inc. • Biological products, (no disgnostic substances) • California
This Sublease Agreement ("Sublease"), dated as of September 30, 2020, but made effective as of August 1, 2020 (the "Effective Date"), is entered into between ALTOR BIOSCIENCE MANUFACTURING COMPANY, LLC, a Delaware limited liability company ("Sublandlord") and NANTKWEST, INC., a Delaware corporation ("Subtenant" and, together with Sublandlord, collectively referred herein as the "Parties" or individually as a "Party").
FIRST AMENDMENT TO FACILITY LICENSE AGREEMENTFacility License Agreement • November 9th, 2020 • NantKwest, Inc. • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO FACILITY LICENSE AGREEMENT (this “First Amendment”), dated as of September 14, 2020, is made and entered into by and between NantWOrks, LLC, a Delaware limited liability company (“Licensor”), and Nantkwest, inc., a Delaware corporation (“Licensee”), with respect to the following facts:
